WHO-GMP Accreditation For Parabolic Cephalosporin Facility


The Company’s dedicated Cephalosporin API manufacturing Site at Derabassi has been accredited with the WHO-GMP certificate by the Central Drugs Standards Control Organization, DGHS, Ministry of Health & Family Welfare.

The Derabassi Campus, housing six manufacturing Plants, two Solvant Recovery Plants, a dedicated Quality Control and Quality Assurance unit, Research & Development wing and Administration blocks was inspected by the Central agency in September and found to be compliant with World health Organization’s Good manufacturing Standards.

This WHO-GMP certificate will give further impetus to Company’s API exports to countries where submission of a “Certificate of Pharmaceutical Product” i.e. COPP issued as per WHO-GMP is a preliminary requirement for marketing in that country.

View Certificate

See also  Parabolic Drugs Limited get approval from Ranbaxy for supply of regulated 6 APA for Ranbaxy’s US markets from PDL’s Panchkula facility, subsequent to PDL filing DMF for USFDA approval in 2005.

Category: Uncategorized